SentryX closes €3.2M seed funding round for the development of next generation pain relief therapeutics
We are delighted with the new investment in SentryX, a next generation, innovative pain relief therapy platform, focusing on orthopedic surgical post-procedural pain.
TargED Biopharmaceuticals appoints Ludo Haazen, M.D. as Chief Medical Officer
TargED Biopharmaceuticals, a biotech spin-off of the University Medical Center Utrecht, today announced the appointment of Ludo Haazen as Chief Medical Officer (CMO).
